Skip to main content

Table 1 Baseline Characteristics MRS ≤ 2

From: Bridging therapy is associated with improved cognitive function after large vessel occlusion stroke – an analysis of the German Stroke Registry

Variable Bridging Non-Bridging p-value
(n = 103) (n = 63)
Sex (n, %)    0.29
 Male 55 (53.4) 39 (61.9)  
 Female 48 (46.6) 24 (38.1)  
Age (mean ± SD) 67 (±14.28) 69 (±11.18) 0.29
Vasc. risk-factors (n, %)
 Art. hypertension 69 (67) 45 (71.4) 0.55
 Smoking 27 (27.3) 23 (37.1) 0.19
 Diabetes 17 (16.5) 14 (22.2) 0.36
 Dyslipidemia 39 (37.9) 23 (36.5) 0.86
 Atrial fibrillation 25 (24.3) 21 (33.3) 0.21
Baseline medication (n, %)
 Aspirin 28 (28.9) 12 (20) 0.22
 Clopidogrel 3 (3.1) 2 (3.3) 0.93
 Anticoagulation 0 (0) 18 (28.6) < 0.001
NIHSS at admission (median points, IQR) 12 (7–16) 10 (5–15) 0.14
Symptom-onset to admission (median time, IQR) 69 (40–171) 205 (73–508) < 0.001
ASPECTS (median points, IQR) 9 (8–10) 8 (7–10) 0.01
General anesthesia (n, %) 68 (66) 41 (65) 0.16
Treatment adverse event (n, %) 12 (11) 8 (12) 0.72
NIHSS at discharge (median points, IQR) 2 (0–4) 2 (1–3) 0.24
mTICI ≥2b after EVT (n, %) 98 (95) 60 (95) 0.65
Stroke etiology (n, %)
 Large-artery atherosclerosis 22 (21) 16 (25) 0.57
 Cardioembolism 37 (36) 27 (43) 0.41
 Small-vessel occlusion 0 (0) 1 (1) 0.38
 Stroke of other determined etiology 9 (9) 2 (3) 0.21
 Stroke of undetermined etiology 23 (22) 15 (24) 0.85
Stroke localization (n, %)
 Right hemispheric stroke 56 (54) 29 (46) 0.44
 Left hemispheric stroke 34 (33) 27 (43) 0.44
 Vertebrobasilar stroke 13 (13) 7 (11) 0.99
 A. cerebri anterior 1 (1) 0 (0) 0.99
 A. cerebri media M1 proximal 33 (32) 28 (44) 0.14
 A. cerebri media M1 distal 26 (25) 14 (22) 0.71
 A. cerebri media M2 23 (22) 13 (21) 0.85
 A. carotis interna T 10 (10) 5 (8) 0.79
 A. carotis interna extracranial 2 (2) 2 (3) 0.64
  1. SD standart deviation, IQR interquartile range